NCT00656669 2023-05-23Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast CancerIndiana UniversityPhase NA Completed23 enrolled 12 charts
NCT00428220 2019-06-27A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.PfizerPhase NA Completed223 enrolled 8 charts